INMUNE BIO INC. Public Float
INMUNE BIO INC. (INMB) had Public Float of $51.00 million as of 2025-06-30, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-30
- 2025-06-30: Entity Public Float $51.00M.
- 2024-06-30: Entity Public Float $135.00M.
- 2023-06-30: Entity Public Float $106.00M.
- 2022-06-30: Entity Public Float $103.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $51.00M 10-K · filed 2026-03-30 |
| 2024-06-30 | $135.00M 10-K · filed 2025-03-27 |
| 2023-06-30 | $106.00M 10-K/A · filed 2024-04-16 |
| 2022-06-30 | $103.00M 10-K · filed 2023-03-02 |
| 2021-06-30 | $157.00M 10-K · filed 2022-03-03 |
| 2020-06-30 | $212.00K 10-K · filed 2021-03-04 |
| 2019-06-30 | $35.00M 10-K · filed 2020-03-11 |
| 2018-06-30 | $0.00 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |